MedPath
FDA Product

Myoview

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Myoview

17156-026

Regulatory Information

17156-026

NDA020372

C73594

December 12, 2022

USA

These highlights do not include all the information needed to use MYOVIEW 30 mL safely and effectively. See full prescribing information for MYOVIEW 30 mL. MYOVIEW 30 mL (Kit for the preparation of technetium Tc99m tetrofosmin injection) for intravenous useInitial U.S. Approval: 1996

HUMAN PRESCRIPTION DRUG LABEL

9

Company Information

095263729

Active Ingredients

Stannous Chloride

Quantity: 0.09 mg in 1 1

Code: 1BQV3749L5

Class Code: IACT

Sodium Bicarbonate

Quantity: 11 mg in 1 1

Code: 8MDF5V39QO

Class Code: IACT

Tetrofosmin

Quantity: 1.38 mg in 1 1

Code: 3J0KPB596Q

Class Code: ACTIB

Ascorbic Acid

Quantity: 3 mg in 1 1

Code: PQ6CK8PD0R

Class Code: IACT

Active Moieties

Tetrofosmin

Code: 3J0KPB596Q

© Copyright 2025. All Rights Reserved by MedPath